Novel environmental toxins: Steryl glycosides as a potential etiological factor for age-related neurodegenerative diseases

Journal of Neuroscience Research

Volumn 85, Issue 2, 2007, Pages 231-237

  Ly, P T T ^a   Singh, S ^a   Shaw, Christopher A ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

ALS PDC; Cycad; Heat shock proteins; Neurodegeneration; Steryl glycoside

Indexed keywords

CAMPESTEROL; DIGITALIN; GLUCOSIDE; GLYCOSIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; LACTATE DEHYDROGENASE; NEUROTOXIN; OUABAIN; SITOGLUSIDE; STEROL GLYCOSIDE; STIGMASTEROL GLUCOSIDE; TOXIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BACTERIAL INFECTION; CELL VIABILITY; CHEMICAL STRUCTURE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CYCADOPHYTA; CYTOTOXICITY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GLYCOSYLATION; GUAM; HELICOBACTER INFECTION; HUMAN; LIPID ANALYSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; POLLUTANT; PRIORITY JOURNAL; SHORT SURVEY;

AGING; ANIMALS; BACTERIA; BACTERIAL INFECTIONS; CYCAS; GLYCOSIDES; HUMANS; NEURODEGENERATIVE DISEASES; NEUROTOXINS;

EID: 33846869461     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21147     Document Type: Short Survey

References (65)

1. Akada JK, Ogura K, Dailidiene D, Dailide G, Cheverud JM, Berg DE. 2003. Helicobacter pylori tissue tropism: mouse-colonizing strains can target different gastric niches. Microbiology 149:1901-1909.
2. Appelmelk BJ, Negrin R, Moran AP, Kuipers EJ. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 5:70-73.
3. Azoyan P, Garnier R, Poitrineau H, Taboulet P. 1991. Acute poisoning by scilliroside. J Toxicol Clin Exp 3:189-192.
4. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 187:23-42.
5. Baseman JB, Tully JG. 1997. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety. Emerg Infect Dis 3:21-32.
6. Bayer AS, Galpin JE, Theofilopoulos AN, Guze LB. 1981. Neurological disease associated with Mycoplasma pneumoniae pneumonitis: demonstration of viable Mycoplasma pneumoniae in cerebrospinal fluid and blood by radioisotopic and immunofluorescent tissue culture techniques. Ann Intern Med, 94:15-20.
7. Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R. 2003. A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A 100:7913-7918.
8. Bodart P, Noirfalise A. 2003. Glycoalkaloids in potatoes. Rev Med Liege 58:25-32.
9. Bouic PJ. 2002. Sterols and sterolins: new drugs for the immune system? Drug Discov Today 7:775-778.
10. Charlett A, Dobbs RJ, Dobbs SM, Weller C, Brady P, Peterson DW. 1999. Parkinsonism: siblings share Helicobacter pylori seropositivity and facets of syndrome. Acta Neurol Scand 99:26-35.
11. Chen S, Le WD, Xie WJ, Alexianu ME, Engelhardt JI, Siklos L, Appel SH. 1998. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol 55:1075-1080.
12. Cruz-Aguado R, Winkler D, Shaw CA. 2006. Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice. Pharmacol Biochem Behav 84:294-299.
13. Demestre M, Pullen A, Orrel ,RW, Orth M. 2005. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem 94:268-275.
14. Flores-Rio de la Loza LJ, Ordonez-Lozano G, Pineda-Olvera B. 2005. Determination of systemic infections due to Mycoplasma in patients with clinically defined amyotrophic lateral sclerosis. Rev Neurol 41:262-267.
15. Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, Sherman MY. 1997. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem 272:18033-18037.
16. Gao J, Wymore RS, Wang Y, Cohen IS, Mathias RT. 2002. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. J Gen Physiol 119:297-312.
17. Gerard HC, Wildt KL, Whittum-Hudson JA, Lai Z, Ager J, Hudson AP. 2005. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathogen 39:19-26.
18. Gething MJ, Sambrook J. 1992. Protein folding in the cell. Nature 355:33-45.
19. Hartl FU. 1996. Molecular chaperones in cellular protein folding. Nature 381:571-579.
20. He Y, Le WD, Appel SH. 2002. Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp Neurol 176:322-327.
21. Hirai Y, Haque M, Yoshida T, Yokota K, Yasuda T, Oguma K. 1995. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J Bacteriol 177:5327-5333.
22. Hirano A, Kurland LT, Krooth RS, Lessell S. 1961. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain 84:642-661.
23. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH. 2003. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74:788-789.
24. Iga DP, Iga S, Schmidt RR, Buzas MC. 2005. Chemical synthesis of cholesteryl beta-D-galactofuranoside and -pyranoside. Carbohydr Res 340:2052-2054.
25. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. 1997. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349:241-244.
26. Kampinga HH. 1993. Thermotolerance in mammalian cells. Protein denaturation and aggregation, and stress proteins. J Cell Sci 104:11-17.
27. Khabazian I, Bains JS, Williams ,DE, Cheung J, Wilson JM, Pasqualotto BA, Pelech SL, Andersen RJ, Wang YT, Liu L, Nagai A, Kim SU, Craig UK, Shaw CA. 2002. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J Neurochem 82:516-528.
28. Kruman II, Kumaravel TS, Lohan ,A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. 2002. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22:1752-1762.
29. Kunimoto S, Kobayashi T, Kobayashi S, Murakami-Murofushi K. 2000. Expression of cholesteryl glucoside by heat shock in human fibroblasts. Cell Stress Chaperones 5:3-7.
30. Kunimoto S, Murofushi W, Kai H, Ishida Y, Uchiyama A, Kobayashi T, Kobayashi S, Murofushi H, Murakami-Murofushi K. 2002. Steryl glucoside is a lipid mediator in stress-responsive signal transduction. Cell Struct Funct 27:157-162.
31. Kunimoto S, Murofushi W, Yamatsu I, Hasegawa Y, Sasaki N, Kobayashi S, Kobayashi T, Murofushi H, Murakami-Murofushi K. 2003. Cholesteryl glucoside-induced protection against gastric ulcer. Cell Struct Funct 28:179-186.
32. Le WD, Rowe DB, Jankovic J, Xie W, Appel SH. 1999. Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch Neurol 56:194-200.
33. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. 2004. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25:419-429.
34. Ly P, Liang X, Wang ,Q, Andreassen K, Shaw C. 2006. Neurotoxic effects of sythetic beta-sitosterol glucoside in NSC34 cells, a motor neuron-derived cell line. Soc Neurosci Abstr(in press).
35. Marler T, Lee V, Shaw CA. 2005. Spatial variation of steryl glucosides in Cycas micronesica plants - within and among plant sampling procedures. Horti Sci (in press).
36. Massa C, Melani C, Colombo MP. 2005. Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res 65:7942-7949.
37. Mattson MP. 2004. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 3:105-120.
38. Miklossy J. 1993. Alzheimer's disease - a spirochetosis? Neuroreport 4:841-848.
39. Misiak M, Kalinowska M, Wojciechowski ZA. 1991. Characterization of acyllipid: sterol glucoside acyltransferase from oat (Avena sativa L.) seedlings. Acta Biochim Pol 38:43-45.
40. Montine TJ, Li K, Perl DP, Galasko D. 2005. Lack of beta-methylamino-1- alanine in brain from controls, AD, or Chamorros with PDC. Neurology 65:768-769.
41. Nestel P. 2002. Tole of soy protein in cholesterol-lowering: how good is it? Arterioscler Thromb Vasc Biol 22:1743-1744.
42. Nicolson GL, Nasralla MY, Haier J, Pomfret J. 2002. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with amyotrophic lateral sclerosis (ALS). J Clin Neurosci 9:525-529.
43. Peng L, Kawagoe Y, Hogan P, Delmer D. 2002. Sitosterol-beta-glucoside as primer for cellulose synthesis in plants. Science 295:147-150.
44. Phillips KM, Ruggio DM, Ashraf-Khorassani M. 2005. Analysis of steryl glucosides in foods and dietary supplements by solid-phase extraction and gas chromatography. J Food Lipids 12:124-135.
45. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W. 2003. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 157:149-157.
46. 2+ enhancement. Acta Neuropathol 107:35-46.
47. Radons J, Multhoff G. 2005. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev 11:17-33.
48. Ross SM, Spencer PS. 1987. Specific antagonism of behanioral action of "uncommon" amino acids linked to motor-system diseases. Synapse 1:248-253.
49. Schulz JD, Hawkes EL, Shaw CA. 2003. A murine model of ALS-PDC with behavioural and neuropathological features of parkinsonism. Ann N Y Acad Sci 991:326-329.
50. Schulz JD, Hawkes EL, Shaw CA. 2006. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypoth 66:1222-1226.
51. Shaw CA, Wilson JM. 2003. Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models. Neurosci Biobehav Rev 27:493-505.
52. Smith PF. 1971. Biosynthesis of cholesteryl glucoside by Mycoplasma gallinarum. J Bacteriol 108:986-991.
53. Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N Engl J Med 347:1175-1186.
54. Susuki K, Odaka M, Mori M, Hirata K, Yuki N. 2004. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62:949-956.
55. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M. 1999. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286:2352-2355.
56. Tanner CM, Ottman R, Goldman SM, Ellenberg J, Chan P, Mayeux R, Langston JW. 1999. Parkinson disease in twins: an etiologic study. JAMA 281:341-346.
57. van Rensburg SJ, Daniels WM, van Zyl JM, Taljaard JJ. 2000. A comparative study of the effects of cholesterol, beta-sitosterol, beta-sitosterol glucoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation. Metab Brain Dis 15:257-265.
58. Wasserstrom JA, Aistrup GL. 2005. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 289:H1781-H1793.
59. Wilson CA, Doms RW, Lee VM. 1999. Intracellular APP processing and A beta production in Alzheimer disease. J Neuropathol Exp Neurol 58:787-794.
60. Wilson JM, Khabazian I, Wong MC, Seyedalikhani A, Bains JS, Pasqualotto BA, Williams DE, Andersen RJ, Simpson RJ, Smith R, Craig UK, Kurland LT, Shaw CA. 2002. Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour. Neuromol Med 1:207-221.
61. Wilson JM, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA. 2004. Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy. Neuroimage 23:336-343.
62. Wilson JM, Tabata R, Shaw CA. 2006. In vivo sterol glucoside neurotoxicity: implications for ALS-PDC and ALS. Soc Neurosci Abstr (in press).
63. Wojciechowski ZA. 1983. The biosynthesis of plant steryl glycosides and saponins. Biochem Soc Trans 11:565-568.
64. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zahringer U, Mollenkopf HJ, Heinz E, Meyer T. 2006. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 12:1030-1038.
65. Zhu H, Guo Q, Mattson MP. 1999. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain Res 842:224-229.